FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yoshiyuki Hattori

Research Profile

Physiology

Anatomy

Chemicals & Drugs

Living Beings

Procedures

Co-author Network

Publications

TOP 3
Yoshiyuki Hattori; Tsukasa Nakamura; Hiroaki Ohno; Nobutaka Fujii; Yoshie Maitani
siRNA delivery into tumor cells by lipid-based nanoparticles composed of hydroxyethylated cholesteryl triamine.
Yoshiyuki Hattori; Tsukasa Nakamura; Hiroaki Ohno; Nobutaka Fujii; Yoshie Maitani
Enhanced plasmid DNA transfer into tumor cells by nanoparticle composed of cholesteryl triamine and diamine.
Go Kamoshida; Kouji Katabami; Takumi Kato; Yoshie Maitani; Ayaka Matsuda; Hiromi Mizuno; Teruaki Oku; Wakana Sekine; Makoto Tsuiji; Yoshiyuki Hattori; Saotomo Itoh; Tsutomu Tsuji
Involvement of transcription factor Ets-1 in the expression of the α3 integrin subunit gene.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yoshiyuki Hattori (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Yoshiyuki Hattori; Tsukasa Nakamura; Hiroaki Ohno; Nobutaka Fujii; Yoshie Maitani
siRNA delivery into tumor cells by lipid-based nanoparticles composed of hydroxyethylated cholesteryl triamine.
International journal of pharmaceutics 2013;443(1-2):221-9.
2013: Yoshiyuki Hattori; Tsukasa Nakamura; Hiroaki Ohno; Nobutaka Fujii; Yoshie Maitani
Enhanced plasmid DNA transfer into tumor cells by nanoparticle composed of cholesteryl triamine and diamine.
Biological & pharmaceutical bulletin 2013;36(5):856-60.
2012: Go Kamoshida; Kouji Katabami; Takumi Kato; Yoshie Maitani; Ayaka Matsuda; Hiromi Mizuno; Teruaki Oku; Wakana Sekine; Makoto Tsuiji; Yoshiyuki Hattori; Saotomo Itoh; Tsutomu Tsuji
Involvement of transcription factor Ets-1 in the expression of the α3 integrin subunit gene.
The FEBS journal 2012;279(24):4535-46.
2012: Mako Kato; Manami Kubo; Yoshiyuki Hattori; Yoshie Maitani
Collagenase-1 injection improved tumor distribution and gene expression of cationic lipoplex.
International journal of pharmaceutics 2012;423(2):428-34.
2011: Tomohiro Izumisawa; Yoshiyuki Hattori; Masataka Date; Kazunori Toma; Yoshie Maitani
Cell line-dependent internalization pathways determine DNA transfection efficiency of decaarginine-PEG-lipid.
International journal of pharmaceutics 2011;404(1-2):264-70.
2011: Yoshiyuki Hattori; Haruya Ubukata; Kumi Kawano; Yoshie Maitani
Angiotensin II-induced hypertension enhanced therapeutic efficacy of liposomal doxorubicin in tumor-bearing mice.
International journal of pharmaceutics 2011;403(1-2):178-84.
2011: Yoshiyuki Hattori; Yuta Ishii; Manami Kubo; Yasuo Nagaoka; Hiroki Nakano; Hiroko Okita; Shinichi Uesato; Haruka Yamasaku; Yoshie Maitani
Antitumor effect of liposomal histone deacetylase inhibitor-lipid conjugates in vitro.
Chemical & pharmaceutical bulletin 2011;59(11):1386-92.
2010: Yoshiyuki Hattori; Naotetsu Kanamoto; Kumi Kawano; Hiroshi Iwakura; Masakatsu Sone; Masako Miura; Akihiro Yasoda; Naohisa Tamura; Hiroshi Arai; Takashi Akamizu; Kazuwa Nakao; Yoshie Maitani
Molecular characterization of tumors from a transgenic mouse adrenal tumor model: comparison with human pheochromocytoma.
International journal of oncology 2010;37(3):695-705.
2010: Yoshiyuki Hattori
Development of non-viral vector for cancer gene therapy.
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2010;130(7):917-23.
2010: Kumiko Goto; Yoshihiko Chiba; Kimihiko Matsusue; Yoshiyuki Hattori; Yoshie Maitani; Hiroyasu Sakai; Shioko Kimura; Miwa Misawa
The proximal STAT6 and NF-kappaB sites are responsible for IL-13- and TNF-alpha-induced RhoA transcriptions in human bronchial smooth muscle cells.
Pharmacological research : the official journal of the Italian Pharmacological Society 2010;61(5):466-72.
2010: Kimiko Koga; Yoshiyuki Hattori; Mihoko Komori; Ryota Narishima; Masahiro Yamasaki; Motoki Hakoshima; Tetsuya Fukui; Yoshie Maitani
Combination of RET siRNA and irinotecan inhibited the growth of medullary thyroid carcinoma TT cells and xenografts via apoptosis.
Cancer science 2010;101(4):941-7.
2010: Yoshiyuki Hattori; Motoki Hakoshima; Kimiko Koga; Yoshie Maitani
Increase of the therapeutic effect by treating nasopharyngeal tumor with combination of HER-2 siRNA and paclitaxel.
International journal of oncology 2010;36(4):1039-46.
2010: Huili Ma; Kouichi Shiraishi; Takuya Minowa; Kumi Kawano; Masayuki Yokoyama; Yoshiyuki Hattori; Yoshie Maitani
Accelerated blood clearance was not induced for a gadolinium-containing PEG-poly(L-lysine)-based polymeric micelle in mice.
Pharmaceutical research 2010;27(2):296-302.
2010: Atsuko Hioki; Ai Wakasugi; Kumi Kawano; Yoshiyuki Hattori; Yoshie Maitani
Development of an in vitro drug release assay of PEGylated liposome using bovine serum albumin and high temperature.
Biological & pharmaceutical bulletin 2010;33(9):1466-70.
2009: Yoshiyuki Hattori; Li Shi; Wuxiao Ding; Kimiko Koga; Kumi Kawano; Motoki Hakoshima; Yoshie Maitani
Novel irinotecan-loaded liposome using phytic acid with high therapeutic efficacy for colon tumors.
Journal of controlled release : official journal of the Controlled Release Society 2009;136(1):30-7.
2009: Masahiko Furuhata; Tomohiro Izumisawa; Hiroko Kawakami; Kazunori Toma; Yoshiyuki Hattori; Yoshie Maitani
Decaarginine-PEG-liposome enhanced transfection efficiency and function of arginine length and PEG.
International journal of pharmaceutics 2009;371(1-2):40-6.
2009: Yoshiyuki Hattori; Kimiko Koga; Tomohiro Izumisawa; Masahiro Yamasaki; Ryota Narishima; Saki Yoshida; Tetsuya Fukui; Yoshie Maitani
The distribution of mRNA expression and protein after hydrodynamic injection of transgene in mice.
Biological & pharmaceutical bulletin 2009;32(4):755-9.
2009: T Fujita; Masahiko Furuhata; Yoshiyuki Hattori; Hiroko Kawakami; Kazunori Toma; Yoshie Maitani
Calcium enhanced delivery of tetraarginine-PEG-lipid-coated DNA/protamine complexes.
International journal of pharmaceutics 2009;368(1-2):186-92.
2009: Wuxiao Ding; Yoshiyuki Hattori; Xianrong Qi; Dai Kitamoto; Yoshie Maitani
Surface properties of lipoplexes modified with mannosylerythritol lipid-a and tween 80 and their cellular association.
Chemical & pharmaceutical bulletin 2009;57(2):138-43.
2009: Wuxiao Ding; Tomohiro Izumisawa; Yoshiyuki Hattori; Xianrong Qi; Dai Kitamoto; Yoshie Maitani
Non-ionic surfactant modified cationic liposomes mediated gene transfection in vitro and in the mouse lung.
Biological & pharmaceutical bulletin 2009;32(2):311-5.
2009: Kumi Kawano; Eri Onose; Yoshiyuki Hattori; Yoshie Maitani
Higher liposomal membrane fluidity enhances the in vitro antitumor activity of folate-targeted liposomal mitoxantrone.
Molecular pharmaceutics 2009;6(1):98-104.
2008: Yoshiyuki Hattori; Takashi Yoshizawa; Kimiko Koga; Yoshie Maitani
NaCl induced high cationic hydroxyethylated cholesterol-based nanoparticle-mediated synthetic small interfering RNA transfer into prostate carcinoma PC-3 cells.
Biological & pharmaceutical bulletin 2008;31(12):2294-301.
2008: Yukino Ohguchi; Kumi Kawano; Yoshiyuki Hattori; Yoshie Maitani
Selective delivery of folate-PEG-linked, nanoemulsion-loaded aclacinomycin A to KB nasopharyngeal cells and xenograft: effect of chain length and amount of folate-PEG linker.
Journal of drug targeting 2008;16(9):660-7.
2008: Takashi Yoshizawa; Yoshiyuki Hattori; Motoki Hakoshima; Kimiko Koga; Yoshie Maitani
Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2008;70(3):718-25.
2008: Yoshiyuki Hattori; Ayako Hagiwara; Wuxiao Ding; Yoshie Maitani
NaCl improves siRNA delivery mediated by nanoparticles of hydroxyethylated cationic cholesterol with amido-linker.
Bioorganic & medicinal chemistry letters 2008;18(19):5228-32.
2008: Takashi Fujita; Masahiko Furuhata; Yoshiyuki Hattori; Hiroko Kawakami; Kazunori Toma; Yoshie Maitani
High gene delivery in tumor by intratumoral injection of tetraarginine-PEG lipid-coated protamine/DNA.
Journal of controlled release : official journal of the Controlled Release Society 2008;129(2):124-7.
2008: Akihiro Hayama; Tatsuhiro Yamamoto; Masayuki Yokoyama; Kumi Kawano; Yoshiyuki Hattori; Yoshie Maitani
Polymeric micelles modified by folate-PEG-lipid for targeted drug delivery to cancer cells in vitro.
Journal of nanoscience and nanotechnology 2008;8(6):3085-90.
2008: Masato Watanabe; Kumi Kawano; Kazunori Toma; Yoshiyuki Hattori; Yoshie Maitani
In vivo antitumor activity of camptothecin incorporated in liposomes formulated with an artificial lipid and human serum albumin.
Journal of controlled release : official journal of the Controlled Release Society 2008;127(3):231-8.
2008: Masahiko Furuhata; Radostin Danev; Kuniaki Nagayama; Yoshifumi Yamada; Hiroko Kawakami; Kazunori Toma; Yoshiyuki Hattori; Yoshie Maitani
Decaarginine-PEG-artificial lipid/DNA complex for gene delivery: nanostructure and transfection efficiency.
Journal of nanoscience and nanotechnology 2008;8(5):2308-15.
2007: Masayoshi Fukushima; Yoshiyuki Hattori; Hideo Tsukada; Kimiko Koga; Eiichi Kajiwara; Kumi Kawano; Tsuneo Kobayashi; Katsuo Kamata; Yoshie Maitani
Adiponectin gene therapy of streptozotocin-induced diabetic mice using hydrodynamic injection.
The journal of gene medicine 2007;9(11):976-85.
2007: Yoshie Maitani; Saki Igarashi; Mamiko Sato; Yoshiyuki Hattori
Cationic liposome (DC-Chol/DOPE=1:2) and a modified ethanol injection method to prepare liposomes, increased gene expression.
International journal of pharmaceutics 2007;342(1-2):33-9.
2007: Yoshiyuki Hattori; Yoshie Maitani
Low-molecular-weight polyethylenimine enhanced gene transfer by cationic cholesterol-based nanoparticle vector.
Biological & pharmaceutical bulletin 2007;30(9):1773-8.
2007: Yoshiyuki Hattori; Wu-Xiao Ding; Yoshie Maitani
Highly efficient cationic hydroxyethylated cholesterol-based nanoparticle-mediated gene transfer in vivo and in vitro in prostate carcinoma PC-3 cells.
Journal of controlled release : official journal of the Controlled Release Society 2007;120(1-2):122-30.
2007: Eiichi Kajiwara; Kumi Kawano; Yoshiyuki Hattori; Masayoshi Fukushima; Kyoko Hayashi; Yoshie Maitani
Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy.
Journal of controlled release : official journal of the Controlled Release Society 2007;120(1-2):104-10.
2007: Yoshiyuki Hattori; Masayoshi Fukushima; Yoshie Maitani
Non-viral delivery of the connexin 43 gene with histone deacetylase inhibitor to human nasopharyngeal tumor cells enhances gene expression and inhibits in vivo tumor growth.
International journal of oncology 2007;30(6):1427-39.
2007: Yoshiyuki Hattori; Yoshie Maitani
DNA/Lipid complex incorporated with fibronectin to cell adhesion enhances transfection efficiency in prostate cancer cells and xenografts.
Biological & pharmaceutical bulletin 2007;30(3):603-7.
2007: Masayoshi Fukushima; Yoshiyuki Hattori; Takashi Yoshizawa; Yoshie Maitani
Combination of non-viral connexin 43 gene therapy and docetaxel inhibits the growth of human prostate cancer in mice.
International journal of oncology 2007;30(1):225-31.
2006: Yoshiyuki Hattori; Yoshie Maitani
Two-step transcriptional amplification-lipid-based nanoparticles using PSMA or midkine promoter for suicide gene therapy in prostate cancer.
Cancer science 2006;97(8):787-98.
2006: Masahiko Furuhata; Hiroko Kawakami; Kazunori Toma; Yoshiyuki Hattori; Yoshie Maitani
Intracellular delivery of proteins in complexes with oligoarginine-modified liposomes and the effect of oligoarginine length.
Bioconjugate chemistry 2006;17(4):935-42.
2006: Yoshiyuki Hattori; Makoto Sakaguchi; Yoshie Maitani
Folate-linked lipid-based nanoparticles deliver a NFkappaB decoy into activated murine macrophage-like RAW264.7 cells.
Biological & pharmaceutical bulletin 2006;29(7):1516-20.
2006: Yuka Hiruta; Yoshiyuki Hattori; Kumi Kawano; Yasuko Obata; Yoshie Maitani
Novel ultra-deformable vesicles entrapped with bleomycin and enhanced to penetrate rat skin.
Journal of controlled release : official journal of the Controlled Release Society 2006;113(2):146-54.
2006: Masahiko Furuhata; Hiroko Kawakami; Kazunori Toma; Yoshiyuki Hattori; Yoshie Maitani
Design, synthesis and gene delivery efficiency of novel oligo-arginine-linked PEG-lipids: effect of oligo-arginine length.
International journal of pharmaceutics 2006;316(1-2):109-16.
2006: Saki Igarashi; Yoshiyuki Hattori; Yoshie Maitani
Biosurfactant MEL-A enhances cellular association and gene transfection by cationic liposome.
Journal of controlled release : official journal of the Controlled Release Society 2006;112(3):362-8.
2006: Yoshie Maitani; Sae Yano; Yoshiyuki Hattori; Masahiko Furuhata; Kyoko Hayashi
Liposome vector containing biosurfactant-complexed DNA as herpes simplex virus thymidine kinase gene delivery system.
Journal of liposome research 2006;16(4):359-72.
2005: Yoshiyuki Hattori; Yoshie Maitani
Folate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinase.
Cancer gene therapy 2005;12(10):796-809.
2005: Kent G Lau; Yoshiyuki Hattori; Sunil Chopra; Edel A O'Toole; Alan Storey; Tsuneji Nagai; Yoshie Maitani
Ultra-deformable liposomes containing bleomycin: in vitro stability and toxicity on human cutaneous keratinocyte cell lines.
International journal of pharmaceutics 2005;300(1-2):4-12.
2005: Yoshiyuki Hattori; Yoshie Maitani
Folate-linked lipid-based nanoparticle for targeted gene delivery.
Current drug delivery 2005;2(3):243-52.
2005: Tomonori Shiokawa; Yoshiyuki Hattori; Kumi Kawano; Yukino Ohguchi; Hiroko Kawakami; Kazunori Toma; Yoshie Maitani
Effect of polyethylene glycol linker chain length of folate-linked microemulsions loading aclacinomycin A on targeting ability and antitumor effect in vitro and in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(5):2018-25.
2004: Yoshiyuki Hattori; Yoshie Maitani
Enhanced in vitro DNA transfection efficiency by novel folate-linked nanoparticles in human prostate cancer and oral cancer.
Journal of controlled release : official journal of the Controlled Release Society 2004;97(1):173-83.
2004: Takahiro Nagamoto; Yoshiyuki Hattori; Kozo Takayama; Yoshie Maitani
Novel chitosan particles and chitosan-coated emulsions inducing immune response via intranasal vaccine delivery.
Pharmaceutical research 2004;21(4):671-4.
2000: Kozo Takayama; A Morva; Mikito Fujikawa; Yoshiyuki Hattori; Yasuko Obata; Tsuneji Nagai
Formula optimization of theophylline controlled-release tablet based on artificial neural networks.
Journal of controlled release : official journal of the Controlled Release Society 2000;68(2):175-86.